IMMX Immix Biopharma Inc

P/E --
Forward P/E --
Price/Sales --
Beta 0.241
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 Immix Biopharma is trading 5.57% up today after Mizuho lifted target to $26

Immix Biopharma is trading 5.57% higher at $12.58 after Mizuho maintained an Outperform rating and raised its price target to $26 from $15. - The analyst...